| 000 | 01664 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515114503.0 | ||
| 264 | 0 | _c20080722 | |
| 008 | 200807s 0 0 eng d | ||
| 022 | _a0143-3636 | ||
| 024 | 7 |
_a10.1097/MNM.0b013e3282f5d2ce _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCicone, Francesco | |
| 245 | 0 | 0 |
_aPrognostic value of FDG uptake by the bone marrow in squamous cell carcinoma of the head and neck. _h[electronic resource] |
| 260 |
_bNuclear medicine communications _cMay 2008 |
||
| 300 |
_a431-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aBelgium _xepidemiology |
| 650 | 0 | 4 |
_aBone Marrow _xdiagnostic imaging |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdiagnostic imaging |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aFluorodeoxyglucose F18 _xpharmacokinetics |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xdiagnostic imaging |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRadionuclide Imaging |
| 650 | 0 | 4 |
_aRadiopharmaceuticals _xpharmacokinetics |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 |
_aRisk Assessment _xmethods |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aSurvival |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aLoose, David | |
| 700 | 1 | _aDeron, Philip | |
| 700 | 1 | _aVermeersch, Hubert | |
| 700 | 1 | _aSignore, Alberto | |
| 700 | 1 | _aVan de Vyvere, Frederic | |
| 700 | 1 | _aScopinaro, Francesco | |
| 700 | 1 | _aVan de Wiele, Christophe | |
| 773 | 0 |
_tNuclear medicine communications _gvol. 29 _gno. 5 _gp. 431-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/MNM.0b013e3282f5d2ce _zAvailable from publisher's website |
| 999 |
_c17890830 _d17890830 |
||